What Sano Genetics does

Sano Genetics Limited is a Cambridge, UK-based precision medicine technology company founded in 2017 by three University of Cambridge PhD students (Patrick Short, Charlotte Guzzo, and William Jones). It operates a 360-degree cloud platform that integrates patient recruitment, prescreening and digital consent, at-home saliva-based DNA testing with end-to-end logistics, electronic medical record retrieval (up to seven years of longitudinal history), biomarker screening, customized patient engagement portals, and study analytics into a single digital workflow aimed at pharmaceutical, biotech, CRO, patient advocacy, and NHS research customers.

Underlying technology centers on a privacy- and security-first architecture (ISO27001, HIPAA, GDPR, Cyber Essentials certified, with optional dedicated cloud deployment) combined with a proprietary patient database and a network of patient advocacy group partnerships that the company uses for recruitment. Specialized product extensions include the DREAM (Data Repository, Exchange, and Analytics platforM) built for the Lupus Research Alliance's Lupus Nexus program, with Lifebit as technology partner, and disease-specific programs spanning MASH, Parkinson's, ALS, Long COVID, and a UK population genomics initiative. Quantified outcomes claimed by the company include up to 10x faster study timelines, up to 55% cost reduction, and 3x faster participant enrollment versus traditional methods.

The business model is a consultative, quote-based enterprise sale with multi-year contracts priced per study; the company does not publish standard pricing tiers. Go-to-market combines direct enterprise field sales with inside sales, supported by content marketing, webinars, case studies, the in-house Genetics Podcast, and participation in industry events. The company is venture-backed (approximately $22M total disclosed funding across seed, Series A, and a Series A follow-on led by Plural in January 2024), reported 5x ARR growth in 2023, and operates with roughly 40 employees across the UK and the US.

Name

Sano Genetics

Legal name

Sano Genetics Limited

Website

https://sanogenetics.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Sano Genetics is a Cambridge, UK-based precision medicine platform company that sells a 360-degree cloud workflow covering patient recruitment, at-home DNA testing, EMR retrieval, and long-term engagement to pharmaceutical, biotech, CRO, patient advocacy, and NHS research customers under quote-based, multi-year enterprise contracts.

Ownership category

akta.pro rank

Product category

Precision Medicine Platform

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Custom Computer Programming Services (541511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

akta.pro secondary industries

Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Precision medicine platform
• Clinical trial recruitment
• Genetic testing services
• Patient engagement software
• Biomarker screening services

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Platform and Services Subscription: Sano Genetics offers its 360-degree platform and associated services (recruitment support, prescreening, DNA testing, EMR retrieval, patient engagement) to pharmaceutical companies, biotechs, and patient advocacy groups. Pricing is customized and quote-based, tailored to each study's goals and scope.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

Sano Genetics operates a 360-degree cloud-based precision medicine platform that connects patient recruitment, prescreening, digital consent, at-home saliva DNA testing, electronic medical record retrieval, biomarker screening, and long-term patient engagement in one unified workflow. The company sells this platform plus associated services (protocol development, recruitment support, DNA testing, EMR retrieval, and patient engagement) to pharmaceutical companies, biotechs, patient advocacy groups, CROs, and NHS/academic research sites running precision medicine studies. Pricing is customized per project and delivered through multi-year subscriptions.

Differentiator

Problem solved

Functional benefit

Products and services

• Sano 360-Degree Precision Medicine Platform

Quantifiable outcome

• Up to 10x faster study timelines for precision medicine teams
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Five partnerships are on record, tiered flagship and supporting.

• Lupus Research AllianceflagshipStrategic or Co-development PartnerCollaborated with the Lupus Research Alliance and Lifebit to build the DREAM (Data Repository, Exchange, and Analytics platforM) platform as part of the Lupus Nexus program. Sano Genetics built and maintains the patient-facing engagement platform for those living with lupus to participate in research.
• LifebitflagshipTechnology or IntegrationPartnered with Sano Genetics on the Lupus Nexus DREAM platform. Lifebit implemented and manages the knowledge-exchange and analytics platform for researchers and clinicians, while Sano drives patient engagement.
• Predictive Health IntelligenceflagshipStrategic or Co-development PartnerSano Genetics partnered with Predictive Health Intelligence on the LiveWell precision liver study, using PHI's hepatoSIGHT case-finding software combined with Sano's platform for recruitment, genetic testing, and participant engagement.
• Somerset NHS Foundation TrustflagshipStrategic or Co-development PartnerClinical oversight and research delivery partner for the LiveWell study, supporting enrollment of 996 participants from a single NHS site. Provided access to NHS patient data and clinical infrastructure.
• Tawazun HealthsupportingStrategic or Co-development PartnerDelivered FibroScan liver assessments as part of the LiveWell study, enabling non-invasive liver diagnostics for participants identified at risk. A CQC-regulated specialist provider of liver assessments.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Antidote (Eversana): Antidote is a patient recruitment and clinical trial matching platform that was acquired by Eversana. It is directly comparable to Sano Genetics' patient finding and prescreening capabilities for precision medicine trials, although without Sano's integrated genetic testing and EMR retrieval.
• Trial Library: Trial Library uses AI to match patients to precision medicine and oncology clinical trials, directly competing with Sano's patient recruitment and biomarker screening capabilities for pharma sponsors.
• Mendel Health: Mendel applies AI to structured and unstructured medical records for clinical trial patient matching and real-world data generation. It competes most directly with Sano's EMR retrieval, prescreening, and analytics layer within the precision medicine trial workflow.
• Deep 6 AI: Deep 6 AI uses AI to mine EHR data for patient cohort identification and clinical trial recruitment. It overlaps with Sano's EMR-based prescreening and patient finding capabilities for pharma and biotech sponsors.

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO with extensive capabilities across clinical trial design, patient recruitment, real-world evidence, and lab services. It is a broad incumbent that competes with Sano on enterprise pharma trial enablement, though without Sano's focus on genetic testing and patient-facing engagement.
• Labcorp Drug Development (Fortrea): Labcorp Drug Development (spun off as Fortrea) is a global CRO offering clinical trial services plus central laboratory and diagnostics capabilities. Its integrated lab and trial services overlap with Sano's genetic testing and trial enablement offerings, though at vastly greater scale and breadth.
• Medidata (Dassault Systèmes): Medidata provides the industry-leading clinical trial technology platform (Rave EDC, eCOA, RTSM, etc.). It is an incumbent in clinical trial informatics that competes broadly with Sano's e-consent and study management capabilities, though it does not offer genetic testing or patient recruitment.

Emerging players

• Seqster: Seqster is a patient-centric health data platform that aggregates genomic, clinical, and wearable data from multiple sources. It is comparable to Sano's patient-driven data integration layer, though its primary focus is longitudinal patient data rather than trial recruitment.
• Color Health: Color Health is a genetics and preventive health company offering at-home genetic testing, screening programs, and clinical research services. Its clinical research arm overlaps with Sano's DNA testing and population genomics programs, though Color focuses more on employer/payer screening.
• Castor: Castor is a clinical trial technology platform offering EDC, ePRO, eConsent, and decentralized trial capabilities. It competes with the study management and digital consent portions of Sano's platform for sponsors running decentralized and precision medicine trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/18190927
• Instagraminstagram.com/sanogenetics
• Xx.com/sanogenetics
• Facebookfacebook.com/sanogenetics

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds9 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sano Genetics